Stay updated with breaking news from Beatriz Garc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ferroglobe PLC (NASDAQ:GSM) Q4 2023 Earnings Call Transcript February 22, 2024 Ferroglobe PLC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning ladies and gentlemen and welcome to Ferroglobe’s Fourth Quarter and Full Year 2023 Earnings Call. At this […]
LONDON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ferroglobe PLC (NASDAQ: GSM) (“Ferroglobe”, the “Company”, or the “Parent”), a leading producer global...
LONDON, Feb. 21, 2024 -- Ferroglobe PLC , a leading producer globally of silicon metal, silicon-based and manganese-based specialty alloys, today announced financial results for the fourth quarter...
A study carried out by the MP20-Biomarkers of Metabolic and Bone Diseases research group at the Biohealth Research Institute in Granada (ibs.GRANADA), led by UGR Professor Manuel Muñoz Torres, has provided significant insights into the role of sclerostin in protecting against atherosclerosis in patients with type 2 diabetes.
Researchers from the Research Institute of Chemical Technology, a joint center of the Spanish National Research Council (CSIC) and the Universitat Politècnica de València (UPV), as well as the ITACA Institute of the UPV, have developed a new, more cost-effective, and sustainable process for producing metal nanocatalysts.